Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss
Sofwave Medical LTD · Lax Skin
Not applicable
Active, not recruiting
30
2026-07
Industry sponsor intelligence
Sofwave Medical LTDClinical Pipeline.
Lead-sponsor view of Sofwave Medical LTD's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 1
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 30
Pipeline overview
Programs by phase and activity.
Velocity
Sofwave Medical LTD trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Tirzepatide → | 1 | 0 | 0 | 0 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Sofwave Medical LTD studies.
This page groups studies where Sofwave Medical LTD is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates